ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HIK Hikma Pharmaceuticals Plc

1,799.00
10.00 (0.56%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  10.00 0.56% 1,799.00 1,805.00 1,807.00 1,807.00 1,763.00 1,786.00 466,727 16:35:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8685 20.78 3.99B

Hikma Pharmaceuticals Plc Director/PDMR Shareholding (0225P)

23/05/2018 10:20am

UK Regulatory


TIDMHIK

RNS Number : 0225P

Hikma Pharmaceuticals Plc

23 May 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------ 
 a)   Name                   John Castellani 
---  ---------------------  ------------------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------------ 
 a)   Position/status        Non-Executive Director 
---  ---------------------  ------------------------------------- 
 b)   Initial notification   Initial notification 
       /Amendment 
---  ---------------------  ------------------------------------- 
 3    Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  ------------------------------------------------------------ 
 a)   Name                   Hikma Pharmaceuticals PLC 
---  ---------------------  ------------------------------------- 
 b)   LEI                    549300BNS685UXH4JI75 
---  ---------------------  ------------------------------------- 
 4    Details of the transaction(s): section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; 
       and (iv) each place where transactions have 
       been conducted 
---  ------------------------------------------------------------ 
 a)   Description            Description: Ordinary shares of 10 
       of the financial       pence each (Shares) 
       instrument,            ID Code: GB00B0LCW083 
       type of instrument 
       and identification 
       code 
---  ---------------------  ------------------------------------- 
 b)   Nature of              Market purchase of 1,000 Ordinary 
       the transaction        Shares by Brown Advisory Investment 
                              Management Firm for and on behalf 
                              of John and Therese Castellani. 
---  ---------------------  ------------------------------------- 
 c)   Price(s) and           Price(s): GBP13.7695 
       volume(s)              Volume(s): 1,000 
---  ---------------------  ------------------------------------- 
 d)   Aggregated 
       information             1,000 
        *    Volume           GBP13,769.50 
 
 
        *    Price 
---  ---------------------  ------------------------------------- 
 e)   Date of the            22 May 2018 
       transaction 
---  ---------------------  ------------------------------------- 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
---  ---------------------  ------------------------------------- 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHGCGDUCBDBGIX

(END) Dow Jones Newswires

May 23, 2018 05:20 ET (09:20 GMT)

1 Year Hikma Pharmaceuticals Chart

1 Year Hikma Pharmaceuticals Chart

1 Month Hikma Pharmaceuticals Chart

1 Month Hikma Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock